Allena Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Allena Pharmaceuticals

01/04/2022 13:05

* Allena Pharmaceuticals Inc  ALNA.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 16 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Allena Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 11 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Allena Pharmaceuticals Inc shares had held steady so far
this
quarter and lost 61.0% so far this year.
    * The company reported a quarterly loss of $10.36 million.
    * Wall Street's median 12-month price target for Allena
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 1 at 12:04 p.m.  ​All
figures in US dollars unless otherwise stated